These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 15818335

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: a pilot efficacy and safety study.
    Fahlke J, Wolff S, Mantke R, Pross M, Weiss G, Buerger T, Lippert H.
    Transplant Proc; 2002 Jun; 34(4):1242-4. PubMed ID: 12072328
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Humanized monoclonal anti-CD25 antibody as a novel therapeutic option in HIV-associated psoriatic erythroderma.
    Dichmann S, Mrowietz U, Schöpf E, Norgauer J.
    J Am Acad Dermatol; 2002 Oct; 47(4):635-6. PubMed ID: 12271320
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantation.
    van Besouw NM, Balk AH, van Vliet M, van der Meide PH, Maat AP, van Gelder T, Baan CC, Weimar W.
    Transplant Proc; 2002 Nov; 34(7):2942-3. PubMed ID: 12431667
    [No Abstract] [Full Text] [Related]

  • 12. Similar survival in patients following heart transplantation receiving induction therapy using daclizumab vs. basiliximab.
    Martin ST, Kato TS, Farr M, McKeen JT, Cheema F, Ji M, Ross A, Yerebakan H, Naka Y, Takayama H, Restaino S, Mancini D, Schulze PC.
    Circ J; 2015 Nov; 79(2):368-374. PubMed ID: 25501951
    [Abstract] [Full Text] [Related]

  • 13. Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.
    Nussenblatt RB, Thompson DJ, Li Z, Chan CC, Peterson JS, Robinson RR, Shames RS, Nagarajan S, Tang MT, Mailman M, Velez G, Roy C, Levy-Clarke GA, Suhler EB, Djalilian A, Sen HN, Al-Khatib S, Ursea R, Srivastava S, Bamji A, Mellow S, Sran P, Waldmann TA, Buggage RR.
    J Autoimmun; 2003 Nov; 21(3):283-93. PubMed ID: 14599854
    [Abstract] [Full Text] [Related]

  • 14. Anti-interleukin-2 receptor antibodies in transplantation: what is the basis for choice?
    Van Gelder T, Warlé M, Ter Meulen RG.
    Drugs; 2004 Nov; 64(16):1737-41. PubMed ID: 15301558
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.